Clinical studies recruiting near Alta

Studies with at least one listed site matching this location on the public registry. Each page explains the study in plain language, with locations and study-team contacts. Clinicians: generate a printable list for your patient →

Prediction of Intraventricular Hemorrhage Using Echocardiography and Near Infrared Spectroscopy
Phase N/A · Mount Sinai Hospital, Canada · NCT05708105 Observational Study Protocol: LIVER-R
Phase N/A · AstraZeneca · NCT06252753 Transpulmonary Assessment for Individualized Lung Optimization in Obese Patients
Phase 2 · University of Alberta · NCT07359261 A Study to Determine the Efficacy and Safety of Finerenone and SGLT2i in Combination in Hospitalized Patients With Heart
Phase 3 · Colorado Prevention Center · NCT06024746 Recombinant Factor VIIa (rFVIIa) for Hemorrhagic Stroke Trial - Part 2
Phase 3 · Joseph Broderick, MD · NCT07227246 This Study Will Explore Whether a Combination of the Investigational Drug Mevrometostat (PF-06821497) and Enzalutamide W
Phase 3 · ICON Cancer Centre - Kurralta Park · Pfizer · NCT07028853 Clinical Investigation of MYIBDDiet App Developed for Inflammatory Bowel Disease (IBD) Patients to Self-manage Their Die
NA · University of Alberta · NCT06683105 A Study of Nemtabrutinib (MK-1026) Versus Comparator (Investigator's Choice of Ibrutinib or Acalabrutinib) in First Line
Phase 3 · Merck Sharp & Dohme LLC · NCT06136559 Phase 2/3 Trial of Izalontamab Brengitecan vs Platinum-based Chemotherapy for Metastatic Urothelial Cancer With Disease
Phase 2/Phase 3 · Bristol-Myers Squibb · NCT07106762 Enhanced MRI Imaging in Healthy Participants and Participants With Epilepsy
Phase 2 · University of Alberta · NCT06483061 Sacituzumab Tirumotecan (MK-2870) Plus Pembrolizumab Versus TPC in TNBC Who Did Not Achieve pCR (MK-2870-012)
Phase 3 · AdventHealth Altamonte Springs ( Site 0125) · Merck Sharp & Dohme LLC · NCT06393374 MYELOMATCH: A Screening Study to Assign People With Myeloid Cancer to a Treatment Study or Standard of Care Treatment Wi
Phase 2 · National Cancer Institute (NCI) · NCT05564390 A Study of the Drug Selinexor With Radiation Therapy in Patients With Newly-Diagnosed Diffuse Intrinsic Pontine (DIPG) G
Phase 1/Phase 2 · National Cancer Institute (NCI) · NCT05099003 Surovatamig as Consolidation Therapy in Participants With Chronic Lymphocytic Leukaemia or Small Lymphocytic Lymphoma Wi
Phase 3 · AstraZeneca · NCT07509151 Dinutuximab With Chemotherapy, Surgery and Stem Cell Transplantation for the Treatment of Children With Newly Diagnosed
Phase 3 · National Cancer Institute (NCI) · NCT06172296 Carotid Intraplaque Neovascularization Combined With Stress Echo
Phase N/A · Dr. Amer Johri · NCT05416385 18F-PSMA-1007 PET/CT in Prostate Cancer - Access Trial 2022 to 2028
Phase 3 · University of Alberta · NCT05520255 Validation of CAGIB Score for In-hospital Mortality of Cirrhotic Patients With Acute Gastrointestinal Bleeding
Phase N/A · Xingshun Qi · NCT04662918 PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease
Phase 2 · Boehringer Ingelheim · NCT07355296 Nonmyeloablative Stem Cell Transplant in Children With Sickle Cell Disease and a Major ABO-Incompatible Matched Sibling
Phase 2 · University of Calgary · NCT03214354 STOP-HAE: A Phase 3 Study of ADX-324 in HAE
Phase 3 · ADARx Pharmaceuticals, Inc. · NCT06960213 Sleep Quality in Assisted-Living Residents
Phase N/A · University of Calgary · NCT04400617 Breakthrough CMV Lung Transplant -Multicentre
Phase N/A · University of Alberta · NCT04439916 UCAN CAN-DU: Canada-Netherlands Personalized Medicine Network in Childhood Arthritis and Rheumatic Disease
Phase N/A · The Hospital for Sick Children · NCT06560606 A Study to Evaluate the Long-term Safety and Tolerability of KarXT and KarX-EC for the Treatment of Schizophrenia and Au
Phase 3 · Karuna Therapeutics, Inc., a Bristol Myers Squibb company · NCT07424404 Venetoclax in Children With Relapsed Acute Myeloid Leukemia (AML)
Phase 3 · PedAL BCU, LLC · NCT05183035 A Study of Lower Radiotherapy Dose to Treat Children With CNS Germinoma
Phase 2 · Children's Oncology Group · NCT06368817 To Evaluate the Safety and Efficacy of MANP in Subjects With Difficult to Control/ Resistant Hypertension
Phase 2 · E-Star BioTech, LLC · NCT06343298 A Study to Test the Addition of the Drug Cabozantinib to Chemotherapy in Patients With Newly Diagnosed Osteosarcoma
Phase 2/Phase 3 · National Cancer Institute (NCI) · NCT05691478 Pediatric Precision Laboratory Advanced Neuroblastoma Therapy
Phase 2 · Giselle Sholler · NCT02559778

Look up another city

Look up another condition